Previous reports showed that PD-L1 can be induced in MDS cells by IFNγ and TNFα (9, 10), although a variety of other factors (i.e., IL-10, FasL, and IL-17A) have been shown to upregulate PD-L1 in other cancer types (11, 12). Here, IL17A is linked to myelodysplastic syndrome.